Bill

Bill > HB1968


TN HB1968

TN HB1968
AN ACT to amend Tennessee Code Annotated, Title 20 and Title 33, relative to opioids.


summary

Introduced
01/22/2026
In Committee
04/07/2026
Crossed Over
Passed
05/18/2026
Dead
Signed/Enacted/Adopted
05/18/2026

Introduced Session

114th General Assembly

Bill Summary

As enacted, adds Alvogen, Inc., Apotex Corp., and Zydus Pharmaceuticals (USA) Inc. to the list of companies that may be released by the attorney general for pending or future claims regarding opioids. - Amends TCA Title 20 and Title 33.

AI Summary

This bill amends Tennessee law to add Alvogen, Inc., Apotex Corp., and Zydus Pharmaceuticals (USA) Inc. to a list of companies that the state's Attorney General may release from pending or future legal claims related to opioids, alongside Purdue Pharma L.P. This action is taken within the context of Tennessee Code Annotated (TCA) sections 20-13-203 and 33-11-103(p), which deal with legal proceedings and opioid-related matters. The bill also includes a severability clause, meaning that if any part of the act is found to be invalid, the rest of the act will still stand.

Committee Categories

Budget and Finance, Justice

Sponsors (1)

Last Action

Comp. became Pub. Ch. 888 (on 05/18/2026)

Bill Topics

Health
  • ‐ Drug Abuse, Treatment, and Education
Law, Crime, and Family Issues
  • ‐ Civil Law and Procedure

bill text


bill summary

Loading...

bill summary

Loading...
Loading...